APA
Revuelta-López E., Núñez J., Gastelurrutia P., Cediel G., Januzzi J. L., Ibrahim N. E., Emdin M., VanKimmenade R., Pascual-Figal D., Núñez E., Gommans F., Lupón J. & Bayés-Genís A. (20210621). Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study. : ESC heart failure.
Chicago
Revuelta-López Elena, Núñez Julio, Gastelurrutia Paloma, Cediel Germán, Januzzi James L, Ibrahim Nasrien E, Emdin Michele, VanKimmenade Roland, Pascual-Figal Domingo, Núñez Eduardo, Gommans Frank, Lupón Josep and Bayés-Genís Antoni. 20210621. Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study. : ESC heart failure.
Harvard
Revuelta-López E., Núñez J., Gastelurrutia P., Cediel G., Januzzi J. L., Ibrahim N. E., Emdin M., VanKimmenade R., Pascual-Figal D., Núñez E., Gommans F., Lupón J. and Bayés-Genís A. (20210621). Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study. : ESC heart failure.
MLA
Revuelta-López Elena, Núñez Julio, Gastelurrutia Paloma, Cediel Germán, Januzzi James L, Ibrahim Nasrien E, Emdin Michele, VanKimmenade Roland, Pascual-Figal Domingo, Núñez Eduardo, Gommans Frank, Lupón Josep and Bayés-Genís Antoni. Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study. : ESC heart failure. 20210621.